Montbretin Clinical Trial (MbA)

Inclusion Criteria: Have diagnosed type-2 diabetes mellitus (previously had HbA1C ≥ 6.5) that is currently controlled by diet (currently HbA1C < 6.5) and no other medication In the opinion of the Medical Expert, have routine and normal dietary habits that include three meals a day; Normal hematological parameters as determined through screeningpre-study blood draw; Use of an effective barrier method of birth control throughout the study, surgical sterility, or menopausal for at least 2 years; Written informed consent; On the Medical Expert's opinion, capable of understanding the visit schedule requirement and study medication dosing requirements. Exclusion Criteria: Currently in poor health as determined by the Medical Expert; Currently on medication, except vitamins and/or birth control; Does not eat three regular meals a day; Currently or historically has/had impairment of gastro-intestinal function. (Specifically, patients who have/had; inflammatory bowel disease, colonic ulceration, partial intestinal obstruction, or in patients predisposed to intestinal obstruction, chronic intestinal diseases associated with marked disorders of digestion or absorption and in patients who suffer from states which may deteriorate as a result of increased gas formation in the intestine, e.g. larger hernias); Has travelled to a foreign country less than four (4) weeks prior to study entry; Has had surgery less than four (4) weeks a prior to study entry; Planned participation with other investigational drugs while participating in the study; Pregnant or lactating women; Known allergy to study medication or its components (non-medicinal ingredients); A history of noncompliance to medical regimens or inability or unwillingness to return for all scheduled visits